Erythrocyte Aggregation and Erythrocyte Membrane Properties in Type 2 Diabetes mellitus and in Vascular Atherosclerotic Disease

• References

• 1 MacRury SM, Lowe GDO. Blood rheology in diabetes mellitus. Diabetic Med 1990; 07: 285-91.
• 2 Ziegler O, Guerci B, Muller S, Candiloros H, Méjean L, Donner M, Stoltz JF, Drouin P. Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis. Metabolism 1994; 43: 1182-6.
• 3 Dormandy JA. Cardiovascular diseases. In: Clinical Hemorheology. Chien S, Dormandy J, Ernst E, Matrai A. eds. Dordrecht: Martinus Nijhoff Publishers; 1987: 165-94.
• 4 Lowe GDO. Blood viscosity and cardiovascular disease. Thromb Haemost 1992; 67: 494-8.
• 5 Demiroglu H, Barista I, Dündar S. Erythrocyte aggregability in patients with coronary heart disease. Clin Hemorheol 1996; 16: 313-7.
• 6 Eisinger J, Flores J. Fluorometry of turbid and absorbant samples and the membrane fluidity of intact erythrocytes. Biophys J 1985; 48: 77-84.
• 7 Ohyashiki T, Yamamoto T, Mohri T. Changes in the fluorescence parameters of bound N-(1-pyrene) maleimide by lipid peroxidation of intestinal brush-border membranes. Biochim Biophys Acta 1989; 981: 235-42.
• 8 Rampling MW, Martin G. A comparison of the Myrenne Erythrocyte Aggregometer with older techniques for estimating erythrocyte aggregation. Clin Hemorheol 1989; 09: 41-6.
• 9 Freyburger G, Gin H, Dousseau F, Lorient-Roudaut MF, Boisseau MR. Erythrocyte membrane fluidity in diabetics: fluorescence measurement and rheological analysis. Clin Hemorheol 1988; 08: 159-64.
• 10 Caimi G, Canino B, Montana M, Ventimiglia G, Catania A, Lo Presti R. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in chronic vascular atherosclerotic disease. Perfusion 1999; 12: 116-22.